[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tenax Therapeutics (TENX)

Tenax Therapeutics (TENX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,824
  • Shares Outstanding, K 37,424
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,600 K
  • EBIT $ -69 M
  • EBITDA $ -69 M
  • 60-Month Beta 0.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.61

Options Overview Details

View History
  • Implied Volatility 104.46% (+7.68%)
  • Historical Volatility 661.82%
  • IV Percentile 33%
  • IV Rank 6.22%
  • IV High 550.27% on 08/07/26
  • IV Low 74.89% on 05/15/26
  • Expected Move (DTE 22) 0.49 (23.25%)
  • Put/Call Vol Ratio 0.22
  • Today's Volume 1,751
  • Volume Avg (30-Day) 5,663
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 66,379
  • Open Int (30-Day) 81,199
  • Expected Range 1.63 to 2.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.38
  • Number of Estimates 4
  • High Estimate $-0.33
  • Low Estimate $-0.47
  • Prior Year $-0.40
  • Growth Rate Est. (year over year) +5.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.31 +61.83%
on 08/10/26
16.50 -87.15%
on 07/28/26
-12.41 (-85.41%)
since 07/24/26
3-Month
1.31 +61.83%
on 08/10/26
19.40 -89.07%
on 07/09/26
-9.86 (-82.30%)
since 05/26/26
52-Week
1.31 +61.83%
on 08/10/26
19.40 -89.07%
on 07/09/26
-3.78 (-64.07%)
since 08/26/25

Most Recent Stories

More News
Tenax Therapeutics (TENX) Securities Investigation Notice - Levi & Korsinsky

Tenax Therapeutics shares fell approximately 84% to 85% after the Company disclosed that its Phase 3 LEVEL trial of TNX-103 missed both its primary and key secondary endpoints. Levi & Korsinsky is investigating...

TENX : 2.12 (-8.62%)
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law

Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tenax Therapeutics, Inc. (“Tenax”...

TENX : 2.12 (-8.62%)
TENX Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Tenax Therapeutics (TENX)

Tenax Therapeutics investors saw the stock decline by roughly 84% to 85% in a single session after the Phase 3 LEVEL trial of TNX-103 failed to meet its primary and key secondary endpoints. Levi & Korsinsky...

TENX : 2.12 (-8.62%)
TENX SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Tenax Therapeutics

Tenax Therapeutics stock lost approximately 84% to 85% of its value in a single trading session after the Phase 3 LEVEL topline readout. SueWallSt notifies investors of a pending investigation into on...

TENX : 2.12 (-8.62%)
Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX)

Tenax Therapeutics shareholders were left holding a substantially lower-valued stock after the Phase 3 LEVEL readout for TNX-103 -- and those losses may carry legal rights.

TENX : 2.12 (-8.62%)
Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

TNX-103 did not meet statistical significance on the primary endpoint of improvement in 6-minute walk distance versus placebo In prespecified exploratory analyses in the overall trial population,...

TENX : 2.12 (-8.62%)
Tenax Therapeutics: Q2 Earnings Snapshot

Tenax Therapeutics: Q2 Earnings Snapshot

TENX : 2.12 (-8.62%)
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL, N.C., July 31, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or...

TENX : 2.12 (-8.62%)
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical...

TENX : 2.12 (-8.62%)
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or “Tenax Therapeutics” or the “Company”), a Phase...

TENX : 2.12 (-8.62%)

Business Summary

Tenax Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market. The Company specializes in creating pharmaceuticals and medical devices in the fields of oxygen therapeutics, blood substitutes, and liquid ventilation...

See More

Key Turning Points

3rd Resistance Point 2.55
2nd Resistance Point 2.47
1st Resistance Point 2.29
Last Price 2.12
1st Support Level 2.03
2nd Support Level 1.95
3rd Support Level 1.77

See More

52-Week High 19.40
Fibonacci 61.8% 12.49
Fibonacci 50% 10.35
Fibonacci 38.2% 8.22
Last Price 2.12
52-Week Low 1.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.